Borderlajn tumor-prikaz slučaja
Sažetak
UVOD: Granično-maligni (“Borderline“) tumori jajnika su najčešće seroznog ili mucinoznog tipa i čine od 1 do 15% svih epitelnih tumora. Ovi tumori se karakterišu niskim malignim potencijalom i najčešće se dijagnostikuju kada dostignu značajnu veličinu, pri čemu uzrokuju abdominalni bol ili distenziju trbuha. Zlatni standard u dijagnostici tumora jajnika predstavlja patohistološki nalaz dobijen pregledom tumorskog tkiva koje je hirurški odstranjeno.
Prikaz slučaja: Pacijentkinja LJ. D., starosti 73 godine, javila se u ambulantu urgentne medicine Opšte bolnice u Ćupriji, sa jakim abdominalnim bolovima, uvećanjem abdomena, opstipacijom u trajanju dužem od 7 dana i smetnjama pri mokrenju, odakle je sa uputnom dijagnozom: Dolor abdominalis inferior, upućena na odeljenje Ginekologije i akušerstva. Nedelju dana pre prijema bila je hospitalizovana na odeljenju urologije zbog sumnje na tumor mokraćne bešike. Ginekološkim pregledom utvrdjeno je da malu karlicu ispunjava tumefakt, trbušni zid je iznad ravni grudnog koša, palpabilna tumorska masa do iznad pupka. Dodatnim dijagnostičkim procedurama je potvrđeno prisustvo tumora i izveden je operativni zahvat. Zaključak: Hirurški tretman predstavlja terapiju izbora u lečenju tumora jajnika, a oblik hirurškog pristupa zavisi od starosne dobi žene, opšteg stanja, želje za očuvanjem fertilne sposobnosti i stadijuma bolesti. U lečenju pacijentkinje čiji je sučaj prikazan, primenjen radikalni hirurški zahvat.
Ključne reči: Granično-maligni (borderline) tumor jajnika, mucinozni cistadenom, prikaz slučaja
Abstract
INTRODUCTION: Borderline ovarian tumors are most commonly serous or mucinous and account for 1 to 15% of all epithelial tumors. These tumors are characterized by low malignant potential and are most often diagnosed when they reach significant size, causing abdominal pain or distension of the abdomen. The gold standard in the diagnosis of ovarian tumors is a pathohistological finding obtained by examination of tumor tissue that has been surgically removed.
Case Report: Patient LJ. D., aged 73, reported to the Emergency Medicine Clinic of the General Hospital in Cuprija, with severe abdominal pain, enlargement of the abdomen, prolongation longer than 7 days, and urinary incontinence, with the following diagnosis: Dolor abdominalis inferior, sent to Department of Gynecology and Obstetrics. One week before her admission, she was hospitalized at the urology department because of suspicion of a bladder tumor. A gynecological examination revealed that a tumor fills the small pelvis; the abdominal wall is above the chest wall, palpable tumor mass above the navel. Additional diagnostic procedures confirmed the presence of tumors and surgery was performed.
Conclusion: Surgery is a treatment therapy for the treatment of ovarian tumors, and the form of surgical approach depends on the age of the woman, the general condition, the desire to preserve fertility and the stage of the disease. In the treatment of a patient whose case was shown, a radical surgical procedure was applied.
Key words: Borderline Ovarian Neoplasms, mucinous cystaden, case report
Reference
Miljuš, D., Živković, S., Plavšić, S., Mickovski-Katalina, N., et al. (2013.). Registar za rak centralne Srbije, Incidenca i mortalitet od raka u centralnoj Srbiji 2011. godine. Institut za Javno zdravlje Srbije „Dr Milan Jovanović Batut“, Beograd.
Đurđević S.,Kesić V. Ginekološka Onkologija. Pažin V.i sar. Maligni tumori jajnika. Novi Sad:Udruženje za ginekološku onkologiju Srbije. Medicinski fakultet Univerziteta u Novom Sadu. 2009. Novi Sad.
Chapman WB. Developments in the pathology of ovarian tumours. Curr Opin Obstet Gynecl 2001; 13:53-9.
Gizzo, S., Berretta, R., Di Gangi, S., Guido, M., et al. Borderline ovarian tumors and diagnostic dilemma of intraoperative diagnosis: could preoperative He4 assay and ROMA score assessment increase the frozen section accuracy? A multicenter case-control study. Biomed Res Int. 2014; 2014: 803598.
Dinulović D. (2007). Savremena ginekologija, Zavod za udžbenike Beograd Beograd.
Terzic, M., Dotlic, J., Likic, I., Brndusic, N., et al. Risk of malignancy index validity assessment in premenopausal and postmenopausal women with adnexal tumors. Taiwan J Obstet Gynecol. 2013; 52(2): 253-257.
Moore RG, McMeekin DS, Brown AK, et al. A Novel Multiple Marker Bioassay Utilizing HE4 And CA125 for the Prediction of Ovarian Cancer in Patients with a Pelvic Mass. Gynecol Oncol. 2009; 112:40.
Ledermann JA, Raja FA, Fotopoulou C, Gonzalez-Martin A, Colombom N, Sessa C. Onbehalf of the ESMO Guidelines Working Group. Newly diagnosed and relapsed epithelialovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and followup. Annals of Oncology 2013; 24:vi24–vi32.
Premal H. Thaker, Anil K. Sood. Molecular Pathogenesis of Ovarian Cancer.In: Gynecological Cancers:a multidisciplinary approach to diagnosis and management. Kunie Odunsi, Tanja Pejovic. Demos Medical Publishing. New York.2014.13:95-104.
Yaker A, Benirschke K. A ten year study of ovarian tumors. Virchows Arch A Pathol Anat Histol. 1975; 366(4):275-86.
Vasconcelos I, Darb-Esfahani S, Sehouli J. Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates. BJOG. 2016; 123(4):498-508.
Ronnett BM, Kajdacsy‐Balla A, Gilks CB, Merino MJ, Silva E, Werness BA, et al. Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior. Hum Pathol 2004; 35:949–60.
Spasić R., Kadija S., Buzadžić S., Likić I. Gigantski asimptomatski borderline tumor jajnika kod bolesnice sa holedoholitijazom i holangitisom. Acta chirurgica iugoslavica. 2012; 59(1):111-4.
Burak Karadag, M Kocak, F Kayıkcioglu, F Ercan, B Dilbaz, MF Kose, A Haberal. Risk for Malignant and Borderline Ovarian Neoplasms Following Basic Preoperative Evaluation by Ultrasonography, Ca125 Level and Age. Asian Pac J Cancer Prev, 15 (19), 8489-93.